U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Fri Dec 15 16:47:27 GMT 2023
Edited
by admin
on Fri Dec 15 16:47:27 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin CHIMERIC (PRIMATE/HUMAN)
Sequence Type COMPLETE
Record UNII
8Z13S29R5A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GOMILIXIMAB
USAN  
USAN  
Official Name English
LUMILIXIMAB [MART.]
Common Name English
Lumiliximab [WHO-DD]
Common Name English
LUMILIXIMAB
INN   MART.   WHO-DD  
INN  
Official Name English
lumiliximab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
Common Name English
ST-152
Code English
PRIMATIZED ANTI-CD23
Common Name English
IDEC-152
Code English
GOMILIXIMAB [USAN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/08/528
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
NCI_THESAURUS C20401
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
FDA ORPHAN DRUG 160502
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
Code System Code Type Description
EVMPD
SUB128912
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
INN
8443
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
FDA UNII
8Z13S29R5A
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
CAS
357613-86-6
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
ChEMBL
CHEMBL2109151
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
USAN
OO-24
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
WIKIPEDIA
Lumiliximab
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
DRUG BANK
DB06162
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
NCI_THESAURUS
C26448
Created by admin on Fri Dec 15 16:47:27 GMT 2023 , Edited by admin on Fri Dec 15 16:47:27 GMT 2023
PRIMARY
From To
1_22 1_98
1_145 1_201
1_221 3_214
1_227 2_227
1_230 2_230
1_262 1_322
1_368 1_426
2_22 2_98
2_145 2_201
2_221 4_214
2_262 2_322
2_368 2_426
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
LOW AFFINITY IMMUNOGLOBULIN EPSILON FC RECEPTOR
TARGET -> INHIBITOR
Kd; Predominant MOA is apoptotic cell death via the intrinsic mitochondrial pathway
Ki
BAND 3 ANION TRANSPORT PROTEIN
TARGET -> INHIBITOR
Related Record Type Details
GOMILIXIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966